Akshay Vaishnaw
Direktor/Vorstandsmitglied bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Akshay Vaishnaw
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.10.2023 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 04.01.2022 | |
| Präsident | 04.01.2022 | 02.10.2023 | |
| EDITAS MEDICINE, INC. | Direktor/Vorstandsmitglied | 28.07.2016 | - |
| Independent Dir/Board Member | 28.07.2016 | - | |
| SCHOLAR ROCK HOLDING CORPORATION | Direktor/Vorstandsmitglied | 21.05.2019 | - |
| Independent Dir/Board Member | 21.05.2019 | - | |
| The Royal College of Physicians | Corporate Officer/Principal | 07.07.2009 | - |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.05.2019 | - |
Karriereverlauf von Akshay Vaishnaw
Ehemalige bekannte Positionen von Akshay Vaishnaw
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VISTERRA INC | Direktor/Vorstandsmitglied | 01.12.2014 | 01.07.2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.1998 | 01.01.2005 |
Ausbildung von Akshay Vaishnaw
| University of London | Doctorate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 5 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Akshay Vaishnaw
- Erfahrung
